M
Markus Naumann
Researcher at University of Würzburg
Publications - 111
Citations - 9132
Markus Naumann is an academic researcher from University of Würzburg. The author has contributed to research in topics: Hyperhidrosis & Botulinum toxin. The author has an hindex of 51, co-authored 111 publications receiving 8659 citations. Previous affiliations of Markus Naumann include University of Medicine and Dentistry of New Jersey & University of California, Los Angeles.
Papers
More filters
Journal ArticleDOI
Pallidal Deep-Brain Stimulation in Primary Generalized or Segmental Dystonia
Andreas Kupsch,Reiner Benecke,Jörg Müller,Thomas Trottenberg,Gerd-Helge Schneider,Werner Poewe,Wilhelm Eisner,Alexander Wolters,Jan-Uwe Müller,Günther Deuschl,Marcus O. Pinsker,Inger Marie Skogseid,Geir Ketil Roeste,Juliane Vollmer-Haase,Angela Brentrup,Martin Krause,Volker M. Tronnier,Alfons Schnitzler,Jürgen Voges,Guido Nikkhah,Jan Vesper,Markus Naumann,Jens Volkmann +22 more
TL;DR: Bilateral pallidal neurostimulation for 3 months was more effective than sham stimulation in patients with primary generalized or segmental dystonia and sustained improvement in all movement symptoms, the level of disability, and quality of life, as compared with baseline scores.
Journal ArticleDOI
Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome.
Alexander Zimprich,Monika Grabowski,Friedrich Asmus,Markus Naumann,Daniela Berg,M. Bertram,Karl Scheidtmann,Peter Kern,Juliane Winkelmann,Bertram Müller-Myhsok,Leonhard Riedel,Matthias F. Bauer,Tanja Müller,Mirna Castro,Thomas Meitinger,Tim M. Strom,Thomas Gasser +16 more
TL;DR: Using a positional cloning approach, five different heterozygous loss-of-function mutations in the gene for ɛ-sarcoglycan (SGCE) are identified, which is mapped to a refined critical region of about 3.2 Mb and shows a marked difference in penetrance depending on the parental origin of the disease allele.
Journal ArticleDOI
Recognition, diagnosis, and treatment of primary focal hyperhidrosis
John Hornberger,Kevin Grimes,Markus Naumann,Dee Anna Glaser,Nicholas J. Lowe,Hans Naver,Samuel Ahn,Lewis P Stolman +7 more
Journal ArticleDOI
Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial
Markus Naumann,Nicholas J. Lowe +1 more
TL;DR: Botulinum toxin type A was significantly better than placebo on all measures of sweating Patient satisfaction was high and few adverse events were reported Effects of treatment remained apparent at 16 weeks.
Journal ArticleDOI
Safety of botulinum toxin type A: a systematic review and meta- analysis
Markus Naumann,Joseph Jankovic +1 more
TL;DR: The results of this meta-analysis and experience from long-term, open-label investigations demonstrate that the formulation of BTX-A evaluated here has a favorable safety and tolerability profile across a broad spectrum of therapeutic uses.